Despite not preventing elesclomol-induced RCD, the combined treatment of elesclomol and Cu in colon cancer cells results in the accumulation of reactive oxygen species and the degradation of solute carrier family 7 member 11 (SLC7A11), which is closely linked to ferroptosis. This evidence concerns the gene SLC7A11 and malignant colon neoplasm.